{
    "doi": "https://doi.org/10.1182/blood.V110.11.2618.2618",
    "article_title": "The Brain Transcription Factor OTX1 Is Activated in Specific Non-Hodgkin Lymphoma Subtypes and Normally Expressed in a Germinal Center-Restricted Small Subpopulation of CD138 + Plasmacell-Like Cells. ",
    "article_date": "November 16, 2007",
    "session_type": "Non-Hodgkin\u2019s Lymphoma - Biology, excluding Therapy",
    "abstract_text": "OTX1 and OTX2 are transcription factors containing a bicoid-like homeodomain and play crucial roles in brain development and in few other body districts as in the case of OTX1, which is required in hematopoiesis for development of the erythroid compartment. Previous studies indicated that in human OTX2 is functionally involved in the generation of anaplastic medulloblastomas; OTX1 expression strongly correlates with nodular/desmoplastic medulloblastomas; and none of them is expressed in other brain tumors. Here we have investigated whether OTX1 and/or OTX2 may potentially be involved in tumors of nonneural origin by focusing on human B-cell non-Hodgkin\u2019s lymphomas (NHLs). We analyzed 184 cases (fig 1)encompassing different NHL subtypes according to the World Health Organization classification and discovered that, while OTX2 expression was never detected, OTX1 was selectively activated in virtually all cases of Diffuse Large B Cell Lymphoma, Burkitt Lymphoma and a relevant fraction of Follicular Cell Lymphomas. In DLBCL lymph nodes and tissue infiltrations, OTX1 protein was detected in the nucleus of PAX5 + -CD20 + cancer cells. Conversely, in nonmalignant lymph nodes and tonsils, OTX1 was expressed in a numerically very small and non-proliferating cell population restricted to the germinal center. These OTX1 + cells were CD138 + -IgG + , about 50% of them also co-expressed both CD10 and CD20 and none of them exhibited PAX5 or BCL6 expression, thus suggesting that OTX1 expression identifies a subset of GC-restricted plasmacell-like cells (fig 2). Interestingly, in contrast with lymphomas, in these cells the OTX1 protein was prevalently localized to the cytoplasm. Collectively, our data suggest that activation of OTX1 expression and its nuclear localization represent together a newly described molecular event occurring in specific NHL subtypes of GC and early post-GC origin (FCL, DLBCL, BL), and lead us to hypothesize that it may be potentially involved (directly or indirectly) in the initiation and/or maintenance of these tumors. View large Download slide Figure View large Download slide Figure Close modal View large Download slide Figure View large Download slide Figure Close modal",
    "topics": [
        "brain",
        "burkitt's lymphoma",
        "cd138",
        "lymphoma, non-hodgkin",
        "transcription factor",
        "diffuse large b-cell lymphoma",
        "lymphoma",
        "cd20 antigens",
        "medulloblastoma",
        "neoplasms"
    ],
    "author_names": [
        "Filippo Russo, MD",
        "Daniela Omodei",
        "Dario Acampora",
        "Rosaria De Filippi, MD",
        "Valeria Severino",
        "Raffaele Di Francia",
        "Ferdinando Frigeri, MD",
        "Pietro Mancuso",
        "Anna De Chiara, MD",
        "Renato Franco, MD",
        "Stefano Casola",
        "Antonio Pinto",
        "Antonio Simeone"
    ],
    "author_dict_list": [
        {
            "author_name": "Filippo Russo, MD",
            "author_affiliations": [
                "Ematologia Oncologica, Istituto Nazionale Tumori, Napoli, Italy",
                " "
            ],
            "author_rank": 1,
            "first_author": 1,
            "last_author": 0
        },
        {
            "author_name": "Daniela Omodei",
            "author_affiliations": [
                "Biotecnologie Avanzate, CEINGE, Naples, Italy",
                " "
            ],
            "author_rank": 2,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Dario Acampora",
            "author_affiliations": [
                "Biotecnologie Avanzate, CEINGE, Naples, Italy",
                " "
            ],
            "author_rank": 3,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Rosaria De Filippi, MD",
            "author_affiliations": [
                "Ematologia Oncologica, Istituto Nazionale Tumori, Napoli, Italy",
                " "
            ],
            "author_rank": 4,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Valeria Severino",
            "author_affiliations": [
                "Biotecnologie Avanzate, CEINGE, Naples, Italy",
                " "
            ],
            "author_rank": 5,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Raffaele Di Francia",
            "author_affiliations": [
                "Ematologia Oncologica, Istituto Nazionale Tumori, Napoli, Italy",
                " "
            ],
            "author_rank": 6,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Ferdinando Frigeri, MD",
            "author_affiliations": [
                "Ematologia Oncologica, Istituto Nazionale Tumori, Napoli, Italy",
                " "
            ],
            "author_rank": 7,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Pietro Mancuso",
            "author_affiliations": [
                "Biotecnologie Avanzate, CEINGE, Naples, Italy",
                " "
            ],
            "author_rank": 8,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Anna De Chiara, MD",
            "author_affiliations": [
                "Anatomia Patologica, Istituto Nazionale Tumori, Naples, Italy",
                " "
            ],
            "author_rank": 9,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Renato Franco, MD",
            "author_affiliations": [
                "Anatomia Patologica, Istituto Nazionale Tumori, Naples, Italy",
                " "
            ],
            "author_rank": 10,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Stefano Casola",
            "author_affiliations": [
                "Oncologia Molecolare, 7IFOM- Fondazione Istituto FIRC di Oncologia Molecolare, Milan, Italy",
                " "
            ],
            "author_rank": 11,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Antonio Pinto",
            "author_affiliations": [
                "Ematologia Oncologica, Istituto Nazionale Tumori, Napoli, Italy",
                " "
            ],
            "author_rank": 12,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Antonio Simeone",
            "author_affiliations": [
                "Biotecnologie Avanzate, CEINGE, Naples, Italy",
                "SEMM European School of Molecular Medicine, Naples, Italy",
                "Institute of Genetics and Biophysics \u201cA. Buzzati-Traverso\u201d, CNR, Naples, Italy",
                " "
            ],
            "author_rank": 13,
            "first_author": 0,
            "last_author": 1
        }
    ],
    "datetime_abstract_obtained": "2022-05-04T06:44:44",
    "is_scraped": "1"
}